Document Detail


New family of peptidomimetics based on the imidazole motif.
MedLine Citation:
PMID:  20939523     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Starting from amino acid esters, new peptidomimetics based on the imidazole scaffold were prepared. An efficient and rapid sequence consisting of two subsequent one-pot procedures was developed and applied to various aminoacids. As they provide more substitution patterns, these heterocyclic mimics are promising tools for structural and biological studies.
Authors:
Sylvain Petit; Corinne Fruit; Laurent Bischoff
Related Documents :
22062643 - Occurrence of conjugated linoleic acid in longissimus dorsi muscle of water buffalo (bu...
6942803 - Significance, mechanisms and control of renal ammoniagenesis.
10836733 - Acid and base catalyzed intramolecular cyclizations of n-benzoylthiocarbamoyl-acetals.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Organic letters     Volume:  12     ISSN:  1523-7052     ISO Abbreviation:  Org. Lett.     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-10-29     Completed Date:  2011-01-28     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100890393     Medline TA:  Org Lett     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4928-31     Citation Subset:  IM    
Affiliation:
IRCOF-INSA Rouen-CNRS UMR 6014 COBRA, Université de Rouen, place Emile Blondel 76130 Mont-Saint-Aignan, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amides / chemistry
Aza Compounds / chemistry
Imidazoles / chemistry*
Molecular Structure
Peptidomimetics / chemistry*
Chemical
Reg. No./Substance:
0/Amides; 0/Aza Compounds; 0/Imidazoles; 0/Peptidomimetics; 288-32-4/imidazole

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Concise synthesis of bicyclic pyridinol antioxidants.
Next Document:  Synthesis, characterization, and in vitro pH-controllable drug release from mesoporous silica sphere...